Your browser doesn't support javascript.
loading
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer, Oliver; Pruschy, Martin; Bender, Sabine; Sharma, Ashish; Bogowicz, Marta; Tanadini-Lang, Stephanie; Stieb, Sonja; Bertogg, Kaja; Weber, Sandra; Ikenberg, Kristian; Huber, Gerhard; Schmid, Stephan; Bredell, Marius; Veit-Haibach, Patrick; Rordorf, Tamara; Held, Ulrike; Glanzmann, Christoph; Studer, Gabriela.
Afiliação
  • Riesterer O; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland; Center for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Switzerland. Electronic address: oliver.riesterer@ksa.ch.
  • Pruschy M; Laboratory for Molecular Radiobiology, University of Zurich, Switzerland.
  • Bender S; Laboratory for Molecular Radiobiology, University of Zurich, Switzerland.
  • Sharma A; Laboratory for Molecular Radiobiology, University of Zurich, Switzerland.
  • Bogowicz M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland.
  • Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland.
  • Stieb S; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland.
  • Bertogg K; Clinical Trials Center, University Hospital Zurich, University of Zurich, Switzerland.
  • Weber S; Clinical Trials Center, University Hospital Zurich, University of Zurich, Switzerland.
  • Ikenberg K; Institute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Switzerland.
  • Huber G; Department of Otorhinolaryngology, University Hospital Zurich, University of Zurich, Switzerland; Department of Otorhinolaryngology, Cantonal Hospital St. Gallen, Switzerland.
  • Schmid S; Otorhinolaryngology Clinic Bethanien, Zurich, Switzerland.
  • Bredell M; Clinic for Oral and Maxillofacial Surgery, University Hospital Zurich, University of Zurich, Switzerland.
  • Veit-Haibach P; Department of Nuclear Medicine, University Hospital Zurich, Switzerland; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Rordorf T; Department of Medical Oncology, University Hospital Zurich, University of Zurich, Switzerland.
  • Held U; Epidemiology, Biostatistics and Prevention Institute, Department of Biostatistics, University of Zurich, Switzerland.
  • Glanzmann C; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland; Department of Radiation Oncology, Cantonal Hospital Lucerne, Switzerland.
  • Studer G; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland; Department of Radiation Oncology, Cantonal Hospital Lucerne, Switzerland.
Radiother Oncol ; 150: 62-69, 2020 09.
Article em En | MEDLINE | ID: mdl-32540337
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article